Franklin Genomic Advancements Etf Market Value
| HELX Etf | USD 28.18 0.50 1.81% |
| Symbol | Franklin |
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Franklin Genomic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Franklin Genomic's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Franklin Genomic.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Franklin Genomic on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Franklin Genomic Advancements or generate 0.0% return on investment in Franklin Genomic over 90 days. Franklin Genomic is related to or competes with Franklin Disruptive, Photronics, and Global X. Under normal market conditions, the fund invests at least 80 percent of its net assets in equity securities of companies... More
Franklin Genomic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Franklin Genomic's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Franklin Genomic Advancements upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 6.06 | |||
| Value At Risk | (2.16) | |||
| Potential Upside | 1.8 |
Franklin Genomic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Franklin Genomic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Franklin Genomic's standard deviation. In reality, there are many statistical measures that can use Franklin Genomic historical prices to predict the future Franklin Genomic's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | 0.0399 | |||
| Treynor Ratio | (0.18) |
Franklin Genomic Adv Backtested Returns
Franklin Genomic Adv secures Sharpe Ratio (or Efficiency) of -0.0869, which denotes the etf had a -0.0869 % return per unit of standard deviation over the last 3 months. Franklin Genomic Advancements exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Franklin Genomic's Mean Deviation of 1.03, standard deviation of 1.32, and Coefficient Of Variation of (1,142) to check the risk estimate we provide. The etf shows a Beta (market volatility) of 0.69, which means possible diversification benefits within a given portfolio. As returns on the market increase, Franklin Genomic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Franklin Genomic is expected to be smaller as well.
Auto-correlation | -0.51 |
Good reverse predictability
Franklin Genomic Advancements has good reverse predictability. Overlapping area represents the amount of predictability between Franklin Genomic time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Franklin Genomic Adv price movement. The serial correlation of -0.51 indicates that about 51.0% of current Franklin Genomic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.51 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.78 |
Franklin Genomic Adv lagged returns against current returns
Autocorrelation, which is Franklin Genomic etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Franklin Genomic's etf expected returns. We can calculate the autocorrelation of Franklin Genomic returns to help us make a trade decision. For example, suppose you find that Franklin Genomic has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Franklin Genomic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Franklin Genomic etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Franklin Genomic etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Franklin Genomic etf over time.
Current vs Lagged Prices |
| Timeline |
Franklin Genomic Lagged Returns
When evaluating Franklin Genomic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Franklin Genomic etf have on its future price. Franklin Genomic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Franklin Genomic autocorrelation shows the relationship between Franklin Genomic etf current value and its past values and can show if there is a momentum factor associated with investing in Franklin Genomic Advancements.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Franklin Genomic Adv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Franklin Genomic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Franklin Genomic Advancements Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Franklin Genomic Advancements Etf:Check out Franklin Genomic Correlation, Franklin Genomic Volatility and Franklin Genomic Alpha and Beta module to complement your research on Franklin Genomic. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Franklin Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.